Relay Therapeutics: Pay

Relay Therapeutics paid its 5 named executives $11.0M in total in FY2025 (Dec). CEO Sanjiv K. Patel, M.D. was paid $4.6M of that.

Pay$100 in the stock at the end of FY20 → $20
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Sanjiv K. Patel, M.D.President and Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Donald Bergstrom, M.D., Ph.D.President, Research & Development
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Thomas CatinazzoChief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Peter RahmerChief Corporate Development Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
4 years
Brian R. AdamsFormer Chief Legal Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 12 peers with pay on file was $7.1M. The CEO of Relay Therapeutics was paid $4.6M, 35% below the median.

  1. 1Cogent Biosciences
  2. 2BridgeBio Pharma
  3. 3Arcus Biosciences
  4. 4Kymera Therapeutics
  5. 5Vir Biotechnology
  6. 6CRISPR Therapeutics AG
  7. 7Arvinas
  8. 8Beam Therapeutics
  9. 9Intellia Therapeutics
  10. 10Denali Therapeutics
  11. 11Relay Therapeutics
  12. 12Schrodinger
  13. 13Tango Therapeutics
  14. 14Alector, Inc.Not disclosed
  15. 15Allogene Therapeutics, Inc.Not disclosed
  16. 16Editas Medicine, Inc.Not disclosed
  17. 17ErascaNot disclosed
  18. 18IGM Biosciences, Inc.Not disclosed
  19. 19Iovance BiotherapeuticsNot disclosed
  20. 20Recursion PharmaceuticalsNot disclosed
  21. 21Sana BiotechnologyNot disclosed
  22. 22SpringWorks Therapeutics, Inc.Not disclosed
  23. 23Zentalis Pharmaceuticals, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.